Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Multi-targeted, NOT gated CAR-T cells as a strategy to protect normal lineages for blood cancer therapy.
Journal: Frontiers in immunology
Published: September 09, 2024
Immune Cell Dynamics in EGFR-Mutated NSCLC Treated With Afatinib and Pembrolizumab: Results From a Phase IB Study.
Journal: JTO clinical and research reports
Published: May 08, 2024
Safety and Efficacy of Osimertinib in the Treatment of a Patient With Metastatic Lung Cancer and Concurrent Somatic EGFR L858R and Germline EGFR T790M Mutations.
Journal: JCO precision oncology
Published: November 01, 2018
Squamous Cell Transformation of Primary Lung Adenocarcinoma in a Patient With EML4-ALK Fusion Variant 5 Refractory to ALK Inhibitors.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: September 29, 2018
Clinical utility of tumor genomic profiling in patients with high plasma circulating tumor DNA burden or metabolically active tumors.
Journal: Journal of hematology & oncology
Published: September 04, 2018
Severe nivolumab-induced pneumonitis preceding durable clinical remission in a patient with refractory, metastatic lung squamous cell cancer: a case report.
Journal: Journal of hematology & oncology
Published: January 16, 2017
Bridging tumor genomics to patient outcomes through an integrated patient-derived xenograft platform.
Journal: Clinical lung cancer
Published: January 29, 2015
Showing 1-7 of 7
Last Updated: 09/26/2026